Market Cap 530.17M
Revenue (ttm) 10.00M
Net Income (ttm) -29.47M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 28,075
Avg Vol 812,584
Day's Range N/A - N/A
Shares Out 140.26M
Stochastic %K 30%
Beta 0.88
Analysts Strong Sell
Price Target $6.80

Company Profile

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab, an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for use in the treatment of tumors. The company is also developing Navicixizumab, which has completed Phase 1b clinical trials for the treatment of the late line ovarian ca...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 33 3023 7300
Address:
One Cavendish Place, 4th Floor, London, United Kingdom
Hoekie12
Hoekie12 Nov. 15 at 9:50 AM
$MREO I remembered this period in 2021. After this price range it broke out to 5 dollar..
0 · Reply
Hoekie12
Hoekie12 Nov. 15 at 9:44 AM
$MREO Even though share prices is down 50% since a year, hedgefunds aren’t selling. They even bought some more 👍🤩 103 million shares 😉 https://fintel.io/so/us/mreo
0 · Reply
Yiethan
Yiethan Nov. 14 at 10:41 PM
$MREO Grok: Ultimate POS Estimate: 95% (Range: 90–98%) Protocols seal it: Favorable powering, ethical design, and surrogate endpoints make failure unlikely (<5% technical miss, e.g., enrollment blips). Matches Ph2 strength + recent optimism (e.g., X threads at 90%). Bull: $12–25/share (milestones/PRV + EU 2027 launch). Data in ~6 weeks—position for volatility, but asymmetry skews positive.
0 · Reply
Yiethan
Yiethan Nov. 14 at 10:39 PM
$MREO Deepseek:Final PoS Estimation: Given that: · The mechanism is proven (massive BMD increases). · The effect on the exact primary endpoint is already proven in a prior cohort (67% fracture reduction, p=0.0014). · The trials are fully enrolled and powered. · The independent DMC has green-lit continuation. · The safety profile is clean and well-understood. The Probability of Success for the Orbit study hitting its primary endpoint is now estimated to be >95%. The Cosmic study, while also likely to succeed, has a slightly different design (open-label, active comparator), but the overwhelming strength of the Orbit data makes the success of the overall program virtually assured. The end of 2025 is poised to be a transformational milestone for Mereo BioPharma and the OI community.
0 · Reply
Berakhot
Berakhot Nov. 14 at 7:39 PM
0 · Reply
Berakhot
Berakhot Nov. 14 at 7:38 PM
0 · Reply
lisaparsons
lisaparsons Nov. 13 at 5:14 PM
$MREO shit i am having to post negativity on every stock. mreo was downgraded yesterday to a strong sell from a hold with zacks. decision time folks. sell for a lost (in my case) and buy back in or pray for a miracle. i like pray for a miracle. lol. anyone have some positve news or views. needed today. thanks blessings to all.
2 · Reply
OutperformGER
OutperformGER Nov. 13 at 4:30 PM
$MREO Jefferies 300% upside if P3 hits 👇
1 · Reply
OutperformGER
OutperformGER Nov. 13 at 8:56 AM
$MREO here we go to next fireside chat 👇
3 · Reply
Berakhot
Berakhot Nov. 13 at 5:16 AM
$MREO Added some recently on these current lows. Will continue to add if it goes lower.
1 · Reply
Latest News on MREO
Mereo BioPharma Provides Update on Lead Clinical Programs

Jan 12, 2025, 11:05 AM EST - 10 months ago

Mereo BioPharma Provides Update on Lead Clinical Programs


Mereo BioPharma Sends Letter to Rubric Capital Management

Aug 31, 2022, 7:00 AM EDT - 3 years ago

Mereo BioPharma Sends Letter to Rubric Capital Management


Why Mereo BioPharma Shares Are Jumping Today

Jun 17, 2022, 10:39 AM EDT - 3 years ago

Why Mereo BioPharma Shares Are Jumping Today


AstraZeneca weighing bid for Mereo BioPharma: report

Jun 17, 2022, 3:44 AM EDT - 3 years ago

AstraZeneca weighing bid for Mereo BioPharma: report

AZN


Hoekie12
Hoekie12 Nov. 15 at 9:50 AM
$MREO I remembered this period in 2021. After this price range it broke out to 5 dollar..
0 · Reply
Hoekie12
Hoekie12 Nov. 15 at 9:44 AM
$MREO Even though share prices is down 50% since a year, hedgefunds aren’t selling. They even bought some more 👍🤩 103 million shares 😉 https://fintel.io/so/us/mreo
0 · Reply
Yiethan
Yiethan Nov. 14 at 10:41 PM
$MREO Grok: Ultimate POS Estimate: 95% (Range: 90–98%) Protocols seal it: Favorable powering, ethical design, and surrogate endpoints make failure unlikely (<5% technical miss, e.g., enrollment blips). Matches Ph2 strength + recent optimism (e.g., X threads at 90%). Bull: $12–25/share (milestones/PRV + EU 2027 launch). Data in ~6 weeks—position for volatility, but asymmetry skews positive.
0 · Reply
Yiethan
Yiethan Nov. 14 at 10:39 PM
$MREO Deepseek:Final PoS Estimation: Given that: · The mechanism is proven (massive BMD increases). · The effect on the exact primary endpoint is already proven in a prior cohort (67% fracture reduction, p=0.0014). · The trials are fully enrolled and powered. · The independent DMC has green-lit continuation. · The safety profile is clean and well-understood. The Probability of Success for the Orbit study hitting its primary endpoint is now estimated to be >95%. The Cosmic study, while also likely to succeed, has a slightly different design (open-label, active comparator), but the overwhelming strength of the Orbit data makes the success of the overall program virtually assured. The end of 2025 is poised to be a transformational milestone for Mereo BioPharma and the OI community.
0 · Reply
Berakhot
Berakhot Nov. 14 at 7:39 PM
0 · Reply
Berakhot
Berakhot Nov. 14 at 7:38 PM
0 · Reply
lisaparsons
lisaparsons Nov. 13 at 5:14 PM
$MREO shit i am having to post negativity on every stock. mreo was downgraded yesterday to a strong sell from a hold with zacks. decision time folks. sell for a lost (in my case) and buy back in or pray for a miracle. i like pray for a miracle. lol. anyone have some positve news or views. needed today. thanks blessings to all.
2 · Reply
OutperformGER
OutperformGER Nov. 13 at 4:30 PM
$MREO Jefferies 300% upside if P3 hits 👇
1 · Reply
OutperformGER
OutperformGER Nov. 13 at 8:56 AM
$MREO here we go to next fireside chat 👇
3 · Reply
Berakhot
Berakhot Nov. 13 at 5:16 AM
$MREO Added some recently on these current lows. Will continue to add if it goes lower.
1 · Reply
Berakhot
Berakhot Nov. 11 at 4:21 PM
0 · Reply
keypatience
keypatience Nov. 11 at 3:03 PM
$MREO Here we go! Run-up to Phase 3 data readout has begun!
1 · Reply
keypatience
keypatience Nov. 11 at 12:19 PM
$MREO Data from Phase 3 Orbit and Cosmic studies of setrusumab in osteogenesis imperfecta on-track for around the end of 2025
1 · Reply
lidopete
lidopete Nov. 11 at 2:25 AM
$MREO Launches Vantictumab- We are excited to have retained European commercial rights in our recent partnership deal with Ashibio for Vantictumab, which is being investigated in autosomal dominant osteopetrosis type 2, another rare bone disease for which promising preclinical data were presented at this year's ASBMR Annual Meeting
0 · Reply
ATML
ATML Nov. 10 at 9:35 PM
$MREO Q3 report looking good.
0 · Reply
keypatience
keypatience Nov. 10 at 8:59 AM
$MREO In December/January Phase 3 data will come out. A significant jump in share price is expected when positive data is released.
1 · Reply
tic2tape
tic2tape Nov. 9 at 4:27 PM
$MREO fireside chat with the CEO probably, where it tanks the stock most of the time 🤣
1 · Reply
lisaparsons
lisaparsons Nov. 8 at 5:05 PM
$MREO is there a next catalyst for mreo? anyone have a great weekend.
0 · Reply
poot_buttagina
poot_buttagina Nov. 7 at 8:13 PM
0 · Reply
ATML
ATML Nov. 7 at 7:20 PM
$MREO FWIW to ease the pain most of those sales were placed on September 30th and beginning of October. They just didn’t file the paperwork till beginning of November. Maybe some tax loss selling to offset the big gains in AI and Quantum??? With more than 30 days after the sale they could begin buying back in when or if they’re still interested.
0 · Reply
lisaparsons
lisaparsons Nov. 7 at 3:19 PM
$MREO well down 55 %. mine as well hold the fuck on and sell if disappointing. this has been torture i hope everyone has some peace this weekend and now. forget this shit.
1 · Reply
MarcusLuttrellHero
MarcusLuttrellHero Nov. 7 at 3:12 PM
$MREO this shit is dead some big boys selling out a week before earnings tells me data is horrible ggs
3 · Reply